These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 27508105)

  • 1. Synthesis and pre-clinical evaluation of an (18)F-labeled single-chain antibody fragment for PET imaging of epithelial ovarian cancer.
    Sharma SK; Wuest M; Way JD; Bouvet VR; Wang M; Wuest FR
    Am J Nucl Med Mol Imaging; 2016; 6(3):185-98. PubMed ID: 27508105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immuno-PET of epithelial ovarian cancer: harnessing the potential of CA125 for non-invasive imaging.
    Sharma SK; Wuest M; Wang M; Glubrecht D; Andrais B; Lapi SE; Wuest F
    EJNMMI Res; 2014 Dec; 4(1):60. PubMed ID: 26116121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical 89Zr Immuno-PET of High-Grade Serous Ovarian Cancer and Lymph Node Metastasis.
    Sharma SK; Sevak KK; Monette S; Carlin SD; Knight JC; Wuest FR; Sala E; Zeglis BM; Lewis JS
    J Nucl Med; 2016 May; 57(5):771-6. PubMed ID: 26837339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved soluble expression of a single-chain antibody fragment in E. coli for targeting CA125 in epithelial ovarian cancer.
    Sharma SK; Suresh MR; Wuest FR
    Protein Expr Purif; 2014 Oct; 102():27-37. PubMed ID: 25079010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of CA125-specific B and T cell responses in patients injected with MAb-B43.13--evidence for antibody-mediated antigen-processing and presentation of CA125 in vivo.
    Noujaim AA; Schultes BC; Baum RP; Madiyalakan R
    Cancer Biother Radiopharm; 2001 Jun; 16(3):187-203. PubMed ID: 11471484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Molecularly Targeted Intraoperative Near-Infrared Fluorescence Imaging Agent for High-Grade Serous Ovarian Cancer.
    Fung K; Sharma SK; Keinänen O; Roche KL; Lewis JS; Zeglis BM
    Mol Pharm; 2020 Aug; 17(8):3140-3147. PubMed ID: 32644804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Prostate-Specific Membrane Antigen (PSMA) with F-18-Labeled Compounds: the Influence of Prosthetic Groups on Tumor Uptake and Clearance Profile.
    Bouvet V; Wuest M; Bailey JJ; Bergman C; Janzen N; Valliant JF; Wuest F
    Mol Imaging Biol; 2017 Dec; 19(6):923-932. PubMed ID: 28639122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiopharmacological evaluation of (18)F-labeled phosphatidylserine-binding peptides for molecular imaging of apoptosis.
    Wuest M; Perreault A; Kapty J; Richter S; Foerster C; Bergman C; Way J; Mercer J; Wuest F
    Nucl Med Biol; 2015 Nov; 42(11):864-74. PubMed ID: 26205076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer.
    Richter S; Wuest M; Krieger SS; Rogers BE; Friebe M; Bergmann R; Wuest F
    Nucl Med Biol; 2013 Nov; 40(8):1025-34. PubMed ID: 23969085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring of immune responses to CA125 with an IFN-gamma ELISPOT assay.
    Schultes BC; Whiteside TL
    J Immunol Methods; 2003 Aug; 279(1-2):1-15. PubMed ID: 12969543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CA125 (MUC16) tumor antigen selectively modulates the sensitivity of ovarian cancer cells to genotoxic drug-induced apoptosis.
    Boivin M; Lane D; Piché A; Rancourt C
    Gynecol Oncol; 2009 Dec; 115(3):407-13. PubMed ID: 19747716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy of human ovarian carcinoma with OvaRex MAb-B43.13 in a human-PBL-SCID/BG mouse model.
    Schultes BC; Zhang C; Xue LY; Noujaim AA; Madiyalakan R
    Hybridoma; 1999 Feb; 18(1):47-55. PubMed ID: 10211788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiopharmacological evaluation of 6-deoxy-6-[18F]fluoro-D-fructose as a radiotracer for PET imaging of GLUT5 in breast cancer.
    Wuest M; Trayner BJ; Grant TN; Jans HS; Mercer JR; Murray D; West FG; McEwan AJ; Wuest F; Cheeseman CI
    Nucl Med Biol; 2011 May; 38(4):461-75. PubMed ID: 21531283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are human anti-idiotypic anti-OC125 antibodies formed after immunization with the anti-CA125 antibody B43.13?
    Reinsberg J; Krebs D
    Hybridoma; 1997 Feb; 16(1):59-63. PubMed ID: 9085130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of activated platelets in a mouse model of carotid artery thrombosis with 18 F-labeled single-chain antibodies.
    Ardipradja K; Yeoh SD; Alt K; O'Keefe G; Rigopoulos A; Howells DW; Scott AM; Peter K; Ackerman U; Hagemeyer CE
    Nucl Med Biol; 2014 Mar; 41(3):229-37. PubMed ID: 24440583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rerouting the metabolic pathway of (18)F-labeled peptides: the influence of prosthetic groups.
    Richter S; Wuest M; Bergman CN; Way JD; Krieger S; Rogers BE; Wuest F
    Bioconjug Chem; 2015 Feb; 26(2):201-12. PubMed ID: 25572982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of CA125 and its kinetic parameters and positron emission tomography/computed tomography (PET/CT) with fluorodeoxyglucose ([
    Palomar Muñoz A; Cordero García JM; Talavera Rubio P; García Vicente AM; González García B; Bellón Guardia ME; Soriano Castrejón Á; Aranda Aguilar E
    Med Clin (Barc); 2018 Aug; 151(3):97-102. PubMed ID: 29276012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical Evaluation of 18F-Labeled Anti-HER2 Nanobody Conjugates for Imaging HER2 Receptor Expression by Immuno-PET.
    Vaidyanathan G; McDougald D; Choi J; Koumarianou E; Weitzel D; Osada T; Lyerly HK; Zalutsky MR
    J Nucl Med; 2016 Jun; 57(6):967-73. PubMed ID: 26912425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of structural alterations on the radiopharmacological profile of
    Tietz O; Marshall A; Bergman C; Wuest M; Wuest F
    Nucl Med Biol; 2018; 62-63():9-17. PubMed ID: 29800798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.